Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
24.74
-0.09 (-0.36%)
At close: Sep 18, 2024, 4:00 PM
25.31
+0.57 (2.30%)
After-hours: Sep 18, 2024, 5:19 PM EDT

Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Nurix Therapeutics stock have an average target of 26.92, with a low estimate of 10 and a high estimate of 36. The average target predicts an increase of 8.81% from the current stock price of 24.74.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $26.92 $27 $36
Change -59.58% +8.81% +9.14% +45.51%

Analyst Ratings

The average analyst rating for NRIX stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 233444
Buy 456788
Hold 111111
Sell 000000
Strong Sell 000000
Total 7910121313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$27$30
Buy Maintains $27$30 +21.26% Sep 4, 2024
Oppenheimer
Oppenheimer
Buy
Maintains
$25$27
Buy Maintains $25$27 +9.14% Aug 14, 2024
Truist Securities
Truist Securities
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +45.51% Jul 31, 2024
JP Morgan
JP Morgan
Buy
Maintains
$31$34
Buy Maintains $31$34 +37.43% Jul 15, 2024
Barclays
Barclays
Buy
Maintains
$20$31
Buy Maintains $20$31 +25.30% Jul 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
59.43M
from 76.99M
Decreased by -22.80%
Revenue Next Year
65.33M
from 59.43M
Increased by 9.92%
EPS This Year
-2.88
from -2.65
EPS Next Year
-2.82
from -2.88
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Nov 30, 2019 Nov 30, 2020 Nov 30, 2021 Nov 30, 2022 Nov 30, 2023 Nov 30, 2024 Nov 30, 2025 Nov 30, 2026
Revenue
31.12M17.82M29.75M38.63M76.99M59.43M65.33M78.97M
Revenue Growth
-16.91%-42.73%66.95%29.84%99.31%-22.80%9.92%20.87%
EPS
-6.59-2.76-2.73-3.71-2.65-2.88-2.82-3.01
EPS Growth
--------
Forward PE
--------
No. Analysts -----151513
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 84.0M 94.5M 221.0M
Avg 59.4M 65.3M 79.0M
Low 28.4M 32.7M n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
9.1%
59.0%
238.2%
Avg
-22.8%
9.9%
20.9%
Low
-63.1%
-45.0%
-

EPS Forecast

EPS 20242025202620272028
High -2.56 -2.02 -1.28
Avg -2.88 -2.82 -3.01
Low -3.22 -3.47 -4.07

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.